BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38909741)

  • 1. IN SEARCH OF MOUSE MODELS FOR EXFOLIATION SYNDROME.
    Kuchtey RW; Insignares S; Yang TS; Kuchtey J
    Am J Ophthalmol; 2024 Jun; ():. PubMed ID: 38909741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Optic Nerve Expansion and Altered Ultrastructure of Elastic Fibers Induced by Lysyl Oxidase Inhibition in a Mouse Model of Marfan Syndrome.
    Wu HJ; Krystofiak E; Kuchtey J; Kuchtey RW
    Am J Pathol; 2024 Jul; 194(7):1317-1328. PubMed ID: 38548269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidase-like 1 deficiency alters ultrastructural and biomechanical properties of the peripapillary sclera in mice.
    Wareham LK; Kuchtey J; Wu HJ; Krystofiak E; Wu Y; Reinhart-King CA; Kuchtey RW
    Matrix Biol Plus; 2022 Dec; 16():100120. PubMed ID: 36060791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged Optic Nerve Axons and Reduced Visual Function in Mice with Defective Microfibrils.
    Wu HJ; Hazlewood RJ; Kuchtey J; Kuchtey RW
    eNeuro; 2018; 5(5):. PubMed ID: 30406200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
    Schlötzer-Schrehardt U; Zenkel M
    Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior.
    Li G; Schmitt H; Johnson WM; Lee C; Navarro I; Cui J; Fleming T; Gomez-Caraballo M; Elliott MH; Sherwood JM; Hauser MA; Farsiu S; Ethier CR; Stamer WD
    FASEB J; 2020 Aug; 34(8):10762-10777. PubMed ID: 32623782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
    Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
    Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
    Aragon-Martin JA; Ritch R; Liebmann J; O'Brien C; Blaaow K; Mercieca F; Spiteri A; Cobb CJ; Damji KF; Tarkkanen A; Rezaie T; Child AH; Sarfarazi M
    Mol Vis; 2008 Mar; 14():533-41. PubMed ID: 18385788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland.
    Jonasson F
    Acta Ophthalmol; 2009 Aug; 87(5):478-87. PubMed ID: 19664108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
    Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
    Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOXL1 folding in exfoliation glaucoma.
    Bernstein AM; Ritch R; Wolosin JM
    Adv Protein Chem Struct Biol; 2019; 118():273-288. PubMed ID: 31928728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in the Uygur population.
    Mayinu ; Chen X
    Mol Vis; 2011; 17():1734-44. PubMed ID: 21738402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Animal Models of Exfoliation Syndrome.
    Anderson MG; Meyer KJ; Hedberg-Buenz A; Fingert JH
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S78-S82. PubMed ID: 29419647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
    Zenkel M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Glaucoma in Exfoliation Syndrome.
    Ozaki M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S83-S86. PubMed ID: 29432334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
    Bernstein AM; Ritch R; Wolosin JM
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonular defects in loxl1-deficient zebrafish.
    Zhang M; Sun S; Wang L; Wang X; Chen T; Chen Z; Jiang Y
    Clin Exp Ophthalmol; 2022 Jan; 50(1):62-73. PubMed ID: 34585825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
    Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
    Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.